NCT00139191View on ClinicalTrials.gov

Study Evaluating the Correlation Between C-11 Acetate Uptake and Retention as Measured by PET and FAS in Prostate Cancer

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 31, 2005

Study Completion Date

May 31, 2006

Conditions
Prostate Cancer
Interventions
PROCEDURE

C-11 acetate PET scan

Trial Locations (3)

02114

Massachusetts General Hospital, Boston

02115

Beth Israel Deaconess Medical Center, Boston

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

Beth Israel Deaconess Medical Center

OTHER

collaborator

Massachusetts General Hospital

OTHER

lead

Dana-Farber Cancer Institute

OTHER

NCT00139191 - Study Evaluating the Correlation Between C-11 Acetate Uptake and Retention as Measured by PET and FAS in Prostate Cancer | Biotech Hunter | Biotech Hunter